MiNK Therapeutics INKT
NASDAQ INKT
$10.06 -0.56 (-5.27%)
At close: Oct 22, 2026 · 4:00 PM EDT

MiNK Therapeutics (INKT) Share-based Compensation (2020 - 2026)

Updated

MiNK Therapeutics' Share-based Compensation was $422,202 in Q2 2026, down 52.9% from $896,552 a year earlier and down 33.0% from the prior quarter.

Analysis

MiNK Therapeutics (INKT) Share-based Compensation (2020 - 2026) Analysis & Trends

On a trailing twelve-month basis, MiNK Therapeutics' Share-based Compensation was $2.24 million through Jun 30, 2026, down 1.3% year-over-year; for FY2025, it came in at $2.67 million, up 47.7% from FY2024.

  • Share-based Compensation shows a five-year compound annual growth rate of 98.0% (FY2020 to FY2025).
  • In earlier years, Share-based Compensation was $1.81 million in FY2024 (-53.1%), $3.86 million in FY2023 (+27.5%), $3.03 million in FY2022 (+73.5%) and $1.74 million in FY2021.
  • The Q2 2026 figure marks the lowest quarterly Share-based Compensation since Q4 2024.
  • Compared with a year earlier, Share-based Compensation was higher in four of the last eight quarters, with growth averaging 4.9%.
  • The best year-over-year quarter for Share-based Compensation over five years was Q1 2022 (growth of 177.5%); the worst was Q4 2024 (a decline of 64.6%).
  • Per Business Quant data, INKT's Share-based Compensation in the three quarters before Q2 2026 was $630,386 (Q1 2026), $565,771 (Q4 2025) and $620,585 (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Stock Comp. (Qtr)
1 Eli Lilly 1,230.11 Bn 1,198.70 Bn 19.71 Bn 201.00 Mn
2 Johnson & Johnson 644.39 Bn 564.25 Bn 17.30 Bn 357.00 Mn
3 AbbVie 503.52 Bn 476.68 Bn 12.70 Bn 166.00 Mn
4 Merck 363.29 Bn 317.72 Bn 12.21 Bn 298.00 Mn
5 Novartis Ag 298.23 Bn 262.62 Bn 11.24 Bn -
6 Astrazeneca 267.53 Bn 241.29 Bn 12.86 Bn -
7 Amgen 241.80 Bn 197.20 Bn 7.24 Bn 165.00 Mn
8 Gilead Sciences 195.07 Bn 169.19 Bn 6.22 Bn 231.00 Mn
9 Pfizer 173.33 Bn 120.28 Bn 10.94 Bn 249.00 Mn
10 MiNK Therapeutics 51.27 Mn 10.08 Mn - 422,000.00
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 422,000.00
Mar 31, 2026 630,382.00
Dec 31, 2025 565,771.00
Sep 30, 2025 621,000.00
Jun 30, 2025 897,000.00
Mar 31, 2025 5,882.00
Dec 31, 2024 390,000.00
Sep 30, 2024 883,000.00
Jun 30, 2024 25,313.00
Mar 31, 2024 27,033.00
Dec 31, 2023 1.10 Mn
Sep 30, 2023 939,000.00
Jun 30, 2023 33,347.00
Mar 31, 2023 33,328.00
Dec 31, 2022 667,785.00
Sep 30, 2022 773,000.00
Jun 30, 2022 3,886.00
Mar 31, 2022 43,733.00
Dec 31, 2021 667,305.00
Sep 30, 2021 387,362.00
API Access

MiNK Therapeutics Share-based Compensation API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=share-based-compensation&ticker=INKT&period=max&api_key=YOUR_API_KEY